Literature DB >> 19796968

Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice.

Thomas Høi-Hansen1, Ulrik Pedersen-Bjergaard, Birger Thorsteinsson.   

Abstract

AIM: No consensus exists on classification of hypoglycemia awareness. We compared three methods for assessment of hypoglycemia awareness in a clinical setting.
METHODS: A questionnaire including the three methods was filled in by 372 outpatients with Type 1 diabetes [43% women, age 51 ± 14 years (mean ± S.D.)], duration of diabetes 24 ± 13 years, and hemoglobin A1c 8.2 ± 1.0%). Method A (Diabetes Care, 17, 697-703) and B (Diabetes Care, 18, 517-522) classify into two degrees of awareness, while Method C (Diabetes/Metabolism Research and Reviews, 19, 232-240) includes three classes.
RESULTS: Normal awareness was reported in 75%, 51%, and 41% (A, B, C); 25% and 28% had impaired awareness (A, B); and 13% were unaware (C); 46% belonged to the intermediate class of impaired awareness (C), while 21% were not classifiable (B). Higher rates of severe hypoglycemic events were reported by patients with impaired awareness (A, B) and unawareness (C) compared to aware patients. Patients with impaired awareness (C) had more severe hypoglycemia than aware patients and less severe hypoglycemia than unaware patients. A lower rate of severe hypoglycemia was reported by aware patients classified by Method C than A. Fractions of patients with normal awareness without an event of severe hypoglycemia were 0.81, 0.86, and 0.91 (A, B, C).
CONCLUSION: All three methods for assessment of hypoglycemia awareness are feasible in clinical practice since the degree of awareness is associated with risk of severe hypoglycemia. The trisected method (C) identifies an intermediate group with impaired awareness and with a risk of severe hypoglycemia that is significantly different from those of aware and unaware patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796968     DOI: 10.1016/j.jdiacomp.2009.07.006

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  19 in total

Review 1.  Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls.

Authors:  Ulrik Pedersen-Bjergaard; Birger Thorsteinsson
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 2.  Can the Routine Use of Patient-Reported Outcome Measures Improve the Delivery of Person-Centered Diabetes Care? A Review of Recent Developments and a Case Study.

Authors:  Soren E Skovlund; T H Lichtenberg; D Hessler; N Ejskjaer
Journal:  Curr Diab Rep       Date:  2019-08-16       Impact factor: 4.810

3.  Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.

Authors:  Anne-Sophie Sejling; Kai H W Lange; Christian S Frandsen; Sarah S Diemar; Lise Tarnow; Jens Faber; Jens J Holst; Bolette Hartmann; Linda Hilsted; Troels W Kjaer; Claus B Juhl; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard
Journal:  Diabetologia       Date:  2015-05-19       Impact factor: 10.122

4.  IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.

Authors:  Yu Kuei Lin; Man Hung; Anu Sharma; Owen Chan; Michael W Varner; Gitana Staskus; Simon J Fisher
Journal:  Endocr Pract       Date:  2019-03-13       Impact factor: 3.443

5.  Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.

Authors:  Isabelle I K Steineck; Ajenthen Ranjan; Signe Schmidt; Trine R Clausen; Jens J Holst; Kirsten Nørgaard
Journal:  Diabetologia       Date:  2019-01-14       Impact factor: 10.122

6.  Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible?

Authors:  Marie Moth Henriksen; Louise Færch; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

7.  A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.

Authors:  Peter Lommer Kristensen; Ulrik Pedersen-Bjergaard; Henning Beck-Nielsen; Kirsten Nørgaard; Hans Perrild; Jens Sandahl Christiansen; Tonny Jensen; Hans-Henrik Parving; Birger Thorsteinsson; Lise Tarnow
Journal:  BMC Endocr Disord       Date:  2012-06-22       Impact factor: 2.763

8.  Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria.

Authors:  Raimund Weitgasser; Sandra Lopes
Journal:  Wien Klin Wochenschr       Date:  2014-11-25       Impact factor: 1.704

9.  Self-reported non-severe hypoglycaemic events in Europe.

Authors:  C G Östenson; P Geelhoed-Duijvestijn; J Lahtela; R Weitgasser; M Markert Jensen; U Pedersen-Bjergaard
Journal:  Diabet Med       Date:  2013-07-26       Impact factor: 4.359

10.  Self-reported frequency and impact of hypoglycemic events in Spain.

Authors:  Domingo Orozco-Beltrán; Pedro Mezquita-Raya; Antonio Ramírez de Arellano; Manuel Galán
Journal:  Diabetes Ther       Date:  2014-02-11       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.